You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

231 Results
Document
Oct 2019
Document
Oct 2019
Document
Oct 2019
Document
Oct 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
fluorouracil,
EPIrubicin,
cyclophosphamide,
DOCEtaxel,
PERTuzumab (Unfunded),
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2023
Document
Dec 2019
Guidelines and Advice
Status: Current
ID: N/A
Version: 2
Jan 2023

Pages